#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Angiosarcoma metastatic Factor IX deficiency Synovitis Leukaemia Erythema Congenital absence of bile ducts Cardiac failure acute Neurofibromatosis Systemic candida Squamous cell carcinoma of the hypopharynx Liver abscess Depression Neovascular age-related macular degeneration Follicular lymphoma stage III Malignant central nervous system neoplasm More trials…

    Learn about Rare Diseases

    VEXAS syndrome – Basic Information Hereditary ataxia – Treatment Cystic fibrosis – Basic Information Haemolytic uraemic syndrome – Treatment Leukoencephalopathy Idiopathic pulmonary fibrosis – Treatment Prolymphocytic leukaemia – Treatment Idiopathic inflammatory myopathy – Trials in Disease Hereditary angioedema with C1 esterase inhibitor deficiency – Life with Disease Synovial sarcoma metastatic – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Certolizumab Pegol Enalapril Cabotegravir Sodium ILOPROST Bedaquiline Ralinepag GSKVX000000034792 Naproxen Sodium Pimavanserin Tartrate Rbd4059 Cenegermin TTX-381 Narsoplimab Fenofibrate Nelarabine Pamiparib Osimertinib Poltreg-T1D Human Von Willebrand Factor Entrectinib More therapies…

    Learn about Your Condition

    Compulsive sexual behaviour Bronchopulmonary dysplasia Ovarian cancer Metastatic neoplasm Corneal dystrophy Adrenocortical carcinoma Vascular malformation Myotonia Colorectal cancer metastatic Corneal graft failure Graft infection Hepatobiliary cancer Chondrosarcoma metastatic Cutaneous calcification Intestinal infarction More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Digestive System Diseases

  • Comparing liquid versus capsule forms of phosphatidylcholine in patients with alcoholic liver disease, chronic hepatitis B, and metabolic liver disease

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Metabolic dysfunction-associated liver disease
    • Alcoholic liver disease
    Bulgaria Germany Poland

  • Study of efavaleukin alfa safety and effectiveness in adults with moderate to severe ulcerative colitis

    Not recruiting

    2 1
    Investigated Diseases:
    • Colitis ulcerative
    Austria Belgium Bulgaria Czechia Denmark Finland +11

  • Study of Efavaleukin Alfa to Treat Adults with Moderate to Severe Ulcerative Colitis

    Not recruiting

    2 1
    Investigated Diseases:
    • Colitis ulcerative
    Austria Belgium Bulgaria Czechia Denmark Finland +11

  • Study of zolbetuximab, pembrolizumab and chemotherapy in adults with HER2-negative, Claudin 18.

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Metastatic gastric cancer
    • Adenocarcinoma gastric
    • Gastric cancer
    Investigated Drugs:
    • Zolbetuximab
    • Capecitabine
    • Fluorouracil
    Belgium Czechia France Germany Italy Lithuania +5

  • Study of FOLFIRI with Domvanalimab and Zimberelimab in patients with advanced gastric or gastro-esophageal junction cancer who progressed after chemotherapy

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Gastric cancer
    Investigated Drugs:
    • Domvanalimab
    • Irinotecan
    • Zimberelimab
    France

  • Comparison of linaprazan glurate versus lansoprazole for healing of erosive esophagitis in adults with gastroesophageal reflux disease

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Lansoprazole
    • LINAPRAZAN GLURATE
    Bulgaria Czechia Germany Hungary Poland Romania
Previous Page
1 … 59 60 61 62 63 … 93
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!